Viscosupplementation Market by Product Type (Single Injection, Three Injection, and Five Injection), by End-Users (Hospitals and Orthopaedic Clinics/ASCs), and by Region (North America, South America, Europe, Asia Pacific, and Middle East and Africa
Bioventus has agreed to a nationwide contract with Aetna Medicare Advantage plans, giving 3 million members access to their single-injection HA product, Durolan
/PRNewswire/ The "Global Viscosupplementation Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company.